NEW YORK--(BUSINESS WIRE)--Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., today announced that it will be participating in the following upcoming conferences:
September 2023
- ATB 2023 Life Sciences Institutional Investor Conference, New York, NY – September 20, 2023
- Benzinga Cannabis Capital Conference, Chicago, IL – September 27, 2023
October 2023
- A.G.P.’s Virtual Cannabis Conference, Virtual – October 4, 2023
- Jefferies Cannabis Summit, New York, NY – October 25, 2023
At each event, members of the management team will participate in fireside chats and host one-on-one investor meetings.
For additional information, please visit the Investor Relations section of the Company’s website at: https://investors.columbia.care.
About Columbia Care
Columbia Care is one of the largest and most experienced cultivators, manufacturers and providers of cannabis products and related services, with licenses in 16 U.S. jurisdictions. Columbia Care operates 125 facilities including 94 dispensaries and 31 cultivation and manufacturing facilities, including those under development. Columbia Care is one of the original multi-state providers of medical cannabis in the U.S. and now delivers industry-leading products and services to both the medical and adult-use markets. In 2021, the company launched Cannabist, its new retail brand, creating a national dispensary network that leverages proprietary technology platforms. The company offers products spanning flower, edibles, oils and tablets, and manufactures popular brands including Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, and Amber. For more information on Columbia Care, please visit www.columbia.care.
